Title : Mutations in GET4 disrupt the transmembrane domain recognition complex pathway.

Pub. Date : 2020 Sep

PMID : 32395830






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Treating fibroblasts with the FDA-approved proteasome inhibitor, Bortezomib (10nM), restored syntaxin 5 localization and nearly normalized the levels of all three TRC proteins. Bortezomib syntaxin 5 Homo sapiens